{"id":144947,"date":"2023-04-12T10:18:03","date_gmt":"2023-04-12T09:18:03","guid":{"rendered":"https:\/\/m3globalresearch.blog\/?p=144947"},"modified":"2023-04-12T10:18:03","modified_gmt":"2023-04-12T09:18:03","slug":"new-oncology-treatments-2023-nsclc-breast-cancer-prostate-cancer-and-leukaemia","status":"publish","type":"post","link":"https:\/\/www.m3globalresearch.com\/blog\/new-oncology-treatments-2023-nsclc-breast-cancer-prostate-cancer-and-leukaemia\/","title":{"rendered":"New Oncology Treatments 2023","gt_translate_keys":[{"key":"rendered","format":"text"}]},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"144947\" class=\"elementor elementor-144947\" data-elementor-settings=\"{&quot;ha_cmc_init_switcher&quot;:&quot;no&quot;}\" data-elementor-post-type=\"post\">\n\t\t\t\t<div class=\"elementor-element elementor-element-f21c53a e-flex e-con-boxed e-con e-parent\" data-id=\"f21c53a\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;_ha_eqh_enable&quot;:false}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t<div class=\"elementor-element elementor-element-1513451 e-flex e-con-boxed e-con e-parent\" data-id=\"1513451\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;_ha_eqh_enable&quot;:false}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t<div class=\"elementor-element elementor-element-a0414e1 e-flex e-con-boxed e-con e-parent\" data-id=\"a0414e1\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;_ha_eqh_enable&quot;:false}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-131a9aa elementor-widget elementor-widget-heading\" data-id=\"131a9aa\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">*The translation of this article in French and Portuguese has been made through machine translation and has not been edited yet. we apologise for any inaccuracies.<\/h2>\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-7b6bb39 elementor-widget elementor-widget-text-editor\" data-id=\"7b6bb39\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p><strong>Oncology and haematology are among the fastest-evolving medical fields. Between January 2020 and March 2023, over 170 new oncology treatments were approved by the <a href=\"https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/oncology-cancer-hematologic-malignancies-approval-notifications\" target=\"_blank\" rel=\"noopener\">FDA<\/a>. New approvals for the first quarter of 2023 include treatments for non-small cell lung cancer (NSCLC), breast cancer, prostate cancer, and leukaemia.<\/strong><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-20caab2 elementor-widget elementor-widget-text-editor\" data-id=\"20caab2\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p>Read about these new cancer treatments and upcoming oncology market research opportunities:<\/p><ul><li><a href=\"#nsclc\">NSCLC Treatments<\/a><\/li><li><a href=\"#breast\">Breast Cancer Treatments<\/a><\/li><li><a href=\"#prostate\">Prostate Cancer Treatments<\/a><\/li><li><a href=\"#leukaemia\">Leukaemia Treatments<\/a><\/li><li><a href=\"#oncs\">Paid Market Research Opportunities for Oncologists and Haematologists<\/a><\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-9f48c22 elementor-widget elementor-widget-spacer\" data-id=\"9f48c22\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-25f7858 e-flex e-con-boxed e-con e-parent\" data-id=\"25f7858\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;_ha_eqh_enable&quot;:false}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-4abe7d5 elementor-widget elementor-widget-menu-anchor\" data-id=\"4abe7d5\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"menu-anchor.default\">\n\t\t\t\t\t\t\t<div class=\"elementor-menu-anchor\" id=\"nsclc\"><\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-efb6fb0 elementor-widget elementor-widget-image\" data-id=\"efb6fb0\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img decoding=\"async\" src=\"https:\/\/www.m3globalresearch.com\/blog\/wp-content\/uploads\/2023\/04\/NSCLC-.jpg\" title=\"NSCLC\" alt=\"NSCLC\" loading=\"lazy\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-4596bcf elementor-widget elementor-widget-spacer\" data-id=\"4596bcf\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-8d52b7c elementor-widget elementor-widget-heading\" data-id=\"8d52b7c\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h3 class=\"elementor-heading-title elementor-size-default\">NSCLC Treatments<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-139a612 elementor-widget elementor-widget-text-editor\" data-id=\"139a612\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p>Lung cancer is the second most prevalent cancer worldwide, following breast cancer.<a href=\"https:\/\/www.wcrf.org\/cancer-trends\/worldwide-cancer-data\/\" target=\"_blank\" rel=\"noopener\">*<\/a> As of 2022, the treatment landscape for NSCLC lung cancer has continued to evolve, providing patients with new treatment options. Some of these approved therapies are:<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-082d475 elementor-widget elementor-widget-text-editor\" data-id=\"082d475\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<ul><li><a href=\"https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-grants-accelerated-approval-fam-trastuzumab-deruxtecan-nxki-her2-mutant-non-small-cell-lung#:~:text=On%20August%2011%2C%202022%2C%20the,%2C%20Daiichi%20Sankyo%2C%20Inc\" target=\"_blank\" rel=\"noopener\">Fam-trastuzumab deruxtecan-nxki<\/a>, the first targeted therapy for advanced NSCLC with the HER2 mutation.<\/li><li><a href=\"https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-grants-accelerated-approval-adagrasib-kras-g12c-mutated-nsclc\" target=\"_blank\" rel=\"noopener\">Adagrasib<\/a>, the second drug to be approved for the treatment of advanced NSCLC with a KRAS G12C mutation.<\/li><li><a href=\"https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-approves-neoadjuvant-nivolumab-and-platinum-doublet-chemotherapy-early-stage-non-small-cell-lung#:~:text=On%20March%204%2C%202022%2C%20the,NSCLC)%20in%20the%20neoadjuvant%20setting\" target=\"_blank\" rel=\"noopener\">Nivolumab<\/a>, approved for patients with early-stage NSCLC (IB-IIIA) in combination with platinum-based chemotherapy before surgery. This is the first immunotherapy approved for adjuvant use.<\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-e727d92 elementor-widget elementor-widget-text-editor\" data-id=\"e727d92\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p>In January 2023, the FDA approved <a href=\"https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-approves-pembrolizumab-adjuvant-treatment-non-small-cell-lung-cancer\" target=\"_blank\" rel=\"noopener\">Pembrolizumab<\/a> for adjuvant treatment following resection and platinum-based chemotherapy in patients with stage IB, II, or IIIA NSCLC.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-a8c72a9 elementor-widget elementor-widget-text-editor\" data-id=\"a8c72a9\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p>In the Phase 3 clinical trial (KEYNOTE-091), Pembrolizumab reduced the risk of disease recurrence or death by 27% versus placebo, and the disease-free survival (DFS) improved by nearly two years (23.8 months). For the first time, there is an adjuvant immunotherapy treatment option for this type of NSCLC regardless of PD-L1 expression.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-d581787 elementor-widget elementor-widget-spacer\" data-id=\"d581787\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-42cf640 e-flex e-con-boxed e-con e-parent\" data-id=\"42cf640\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;_ha_eqh_enable&quot;:false}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-93352f7 elementor-widget elementor-widget-menu-anchor\" data-id=\"93352f7\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"menu-anchor.default\">\n\t\t\t\t\t\t\t<div class=\"elementor-menu-anchor\" id=\"breast\"><\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-62bab8e elementor-widget elementor-widget-image\" data-id=\"62bab8e\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img decoding=\"async\" src=\"https:\/\/www.m3globalresearch.com\/blog\/wp-content\/uploads\/2023\/04\/Breast-cancer.jpg\" title=\"breast cancer\" alt=\"breast cancer\" loading=\"lazy\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-4dc2225 elementor-widget elementor-widget-spacer\" data-id=\"4dc2225\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-9608d8f elementor-widget elementor-widget-heading\" data-id=\"9608d8f\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h3 class=\"elementor-heading-title elementor-size-default\">Breast Cancer Treatments<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-bbc75dc elementor-widget elementor-widget-text-editor\" data-id=\"bbc75dc\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p>Since 2008, breast cancer incidence rates have increased globally by more than 20%, with mortality rates also increasing by 14%.<a href=\"https:\/\/www.bcrf.org\/breast-cancer-statistics-and-resources\/\" target=\"_blank\" rel=\"noopener\">*<\/a> Among women, breast cancer is the most common cancer, making it the world\u2019s most prevalent cancer today.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-c650b8a elementor-widget elementor-widget-text-editor\" data-id=\"c650b8a\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<ul><li><a href=\"https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-approves-elacestrant-er-positive-her2-negative-esr1-mutated-advanced-or-metastatic-breast-cancer\" target=\"_blank\" rel=\"noopener\">Elacestrant<\/a>, an estrogen receptor antagonist used to treat postmenopausal women and adult men with estrogen receptor-positive, HER2-negative breast cancer that has a mutation in the ESR1 gene and is advanced or has spread to other parts of the body. The medication binds to proteins called estrogen receptors, which are found in some breast cancer cells and may cause cancer cells to grow. Elacestrant blocks these proteins and may keep cancer cells from growing.<\/li><li><a href=\"https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-approves-sacituzumab-govitecan-hziy-hr-positive-breast-cancer\" target=\"_blank\" rel=\"noopener\">Sacituzumab govitecan-hziy<\/a>, is an antibody drug used to treat triple-negative breast cancer that has spread (metastatic) or cannot be removed by surgery (unresectable locally advanced), among others. It is given to patients who have received two or more cancer treatments, including at least one treatment for metastatic disease. The medication interferes with the growth of cancer cells, which are eventually destroyed.<\/li><li><a href=\"https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-expands-early-breast-cancer-indication-abemaciclib-endocrine-therapy\" target=\"_blank\" rel=\"noopener\">Abemaciclib<\/a>, a targeted therapy drug used alongside endocrine therapy to treat estrogen receptor positive, HER2 negative, and node-positive early breast cancer at high risk of recurrence. Patients defined as high risk include those having either four or more pathologic axillary lymph nodes or one to three pathologic axillary lymph nodes and either a grade 3 tumour or a tumour \u2265 50 mm. Abemaciclib was previously approved for the above high-risk population with the additional requirement of having a Ki67 score of \u2265 20%; the new approval removes the Ki67 testing requirement.<\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-b01a169 elementor-widget elementor-widget-spacer\" data-id=\"b01a169\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-ea130aa elementor-widget elementor-widget-menu-anchor\" data-id=\"ea130aa\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"menu-anchor.default\">\n\t\t\t\t\t\t\t<div class=\"elementor-menu-anchor\" id=\"prostate\"><\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-69d158a elementor-widget elementor-widget-image\" data-id=\"69d158a\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img decoding=\"async\" src=\"https:\/\/www.m3globalresearch.com\/blog\/wp-content\/uploads\/2023\/04\/prostate-cancer-scaled.jpg\" title=\"prostate cancer\" alt=\"prostate cancer\" loading=\"lazy\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-f98847f elementor-widget elementor-widget-spacer\" data-id=\"f98847f\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-ce4d01e elementor-widget elementor-widget-heading\" data-id=\"ce4d01e\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h3 class=\"elementor-heading-title elementor-size-default\">Prostate Cancer Treatments<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-78eaf26 elementor-widget elementor-widget-text-editor\" data-id=\"78eaf26\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p>According to <a href=\"https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/cancer\" target=\"_blank\" rel=\"noopener\">WHO<\/a>, prostate cancer is among the top five most common cancers worldwide and the second most commonly occurring cancer in men. Treatment usually includes surgery, radiotherapy, and\/or systemic therapy (chemotherapy, hormonal treatments, targeted biological therapies).<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-b63e6d5 elementor-widget elementor-widget-text-editor\" data-id=\"b63e6d5\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p>In March 2022, <a href=\"https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-approves-pluvicto-metastatic-castration-resistant-prostate-cancer\" target=\"_blank\" rel=\"noopener\">Pluvicto<\/a> was approved for the treatment of advanced prostate cancer. Pluvicto is a precision cancer treatment that combines a targeting compound (ligand) with a therapeutic radioisotope (a radioactive particle). The therapy works by locating prostate cancer cells that express a biomarker called prostate-specific membrane antigen (PSMA). Once the biomarker is identified, the drug attaches itself to the cancer cell and delivers radiation that kills off the cell and others around it.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-1dcd297 elementor-widget elementor-widget-text-editor\" data-id=\"1dcd297\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p>There are yet to be any new treatment approvals for prostate cancer by the FDA in 2023, however, multiple phase III clinical trials show promising results. Many of which are combination treatments of already approved drugs.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-799d704 elementor-widget elementor-widget-text-editor\" data-id=\"799d704\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p>The findings from the Phase 3 TALAPRO-2 Study indicated that the <a href=\"https:\/\/www.fda.gov\/drugs\/drug-approvals-and-databases\/fda-approves-talazoparib-gbrcam-her2-negative-locally-advanced-or-metastatic-breast-cancer\" target=\"_blank\" rel=\"noopener\">Talazoparib<\/a> and <a href=\"https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-approves-enzalutamide-metastatic-castration-sensitive-prostate-cancer\" target=\"_blank\" rel=\"noopener\">Enzalutamide<\/a> combination therapy resulted in a 37% reduction in the risk of disease progression or death in men with metastatic castration-resistant prostate cancer. This treatment combination outperformed the placebo in treating this condition. The research team believes this new treatment combination will add significant clinical benefits for patients with metastatic castration-resistant prostate cancer (mCRPC).<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-d4be771 elementor-widget elementor-widget-spacer\" data-id=\"d4be771\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-53b179e elementor-widget elementor-widget-menu-anchor\" data-id=\"53b179e\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"menu-anchor.default\">\n\t\t\t\t\t\t\t<div class=\"elementor-menu-anchor\" id=\"leukaemia\"><\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-5a5dde2 elementor-widget elementor-widget-image\" data-id=\"5a5dde2\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img decoding=\"async\" src=\"https:\/\/www.m3globalresearch.com\/blog\/wp-content\/uploads\/2023\/04\/leukaemia.jpg\" title=\"leukaemia\" alt=\"leukaemia\" loading=\"lazy\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-b09ba35 elementor-widget elementor-widget-spacer\" data-id=\"b09ba35\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-aef562c elementor-widget elementor-widget-heading\" data-id=\"aef562c\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h3 class=\"elementor-heading-title elementor-size-default\">Leukaemia Treatments<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-fd171a6 elementor-widget elementor-widget-text-editor\" data-id=\"fd171a6\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p>Globally in 2020, leukaemia accounted for approximately 2.5% of all new cancer incidences and 3.1% of cancer-related mortality.<a href=\"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.904292\/full\" target=\"_blank\" rel=\"noopener\">*<\/a> Chemotherapy is the main treatment for many kinds of leukaemia and radiation therapy is most often used to prevent leukaemia from spreading or to prepare the bone marrow for stem cell transplant.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-49cd9aa elementor-widget elementor-widget-text-editor\" data-id=\"49cd9aa\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p>Between 2021-2022, eight new treatment options were approved for leukaemia, including <a href=\"https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-approves-olutasidenib-relapsed-or-refractory-acute-myeloid-leukemia-susceptible-idh1-mutation\" target=\"_blank\" rel=\"noopener\">Olutasidenib<\/a> for patients with relapsed or refractory acute myeloid leukemia. This year, the FDA approved <a href=\"https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-approves-zanubrutinib-chronic-lymphocytic-leukemia-or-small-lymphocytic-lymphoma\" target=\"_blank\" rel=\"noopener\">Zanubrutinib<\/a>, a new treatment for people with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL).<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-c4780d3 elementor-widget elementor-widget-text-editor\" data-id=\"c4780d3\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p>Clinical trial results show that Zanubrutinib has fewer side effects compared with other non-chemotherapy treatments for na\u00efve patients with CLL, which is the most prevalent form of leukemia in adults.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-1fc9810 elementor-widget elementor-widget-text-editor\" data-id=\"1fc9810\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p>The treatment inhibits a protein called BTK that fuels the growth and survival of CLL cells. In clinical trials, after two years of treatment, more than 78% of patients receiving Zanubrutinib remained alive with no cancer growth, compared to 66% of patients receiving other treatments.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-5bd2d53 elementor-widget elementor-widget-spacer\" data-id=\"5bd2d53\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-ee8deb4 elementor-widget elementor-widget-menu-anchor\" data-id=\"ee8deb4\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"menu-anchor.default\">\n\t\t\t\t\t\t\t<div class=\"elementor-menu-anchor\" id=\"oncs\"><\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-74fe4aa elementor-widget elementor-widget-image\" data-id=\"74fe4aa\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img decoding=\"async\" src=\"https:\/\/www.m3globalresearch.com\/blog\/wp-content\/uploads\/2023\/04\/oncology-treatments--scaled.jpg\" title=\"oncology treatments\" alt=\"oncology treatments\" loading=\"lazy\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-bc6580d elementor-widget elementor-widget-spacer\" data-id=\"bc6580d\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-fb22ab6 elementor-widget elementor-widget-heading\" data-id=\"fb22ab6\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h3 class=\"elementor-heading-title elementor-size-default\">Upcoming Paid Market Research Opportunities for Oncologists and Haematologists<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-39803b9 elementor-widget elementor-widget-text-editor\" data-id=\"39803b9\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p>With more than ten new FDA-approved oncology treatments entering the healthcare market in the first quarter of 2023 alone, the demand for oncology market research will likely increase throughout the year. As hospitals, physicians, and patients are introduced to these new drugs and treatments, pharmaceutical companies seek continuous feedback from consumers about how they are used and perceived to further develop their products and services.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-9fd509d elementor-widget elementor-widget-text-editor\" data-id=\"9fd509d\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p>Market research in healthcare serves as a bridge between research and practice. It helps doctors and nurses improve quality, keeps patients safe, and provides data to track the ever-evolving healthcare system. It\u00b4s a way for life science organisations to gain insights directly from healthcare professionals and patients to make informed decisions about future applications and improvements.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-3b66881 elementor-widget elementor-widget-text-editor\" data-id=\"3b66881\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p>If you are working as an oncologist or haematologist treating patients living with NSCLC, breast cancer, prostate cancer, or leukaemia, you can provide your feedback and opinion on new cancer treatments by signing up for our global <a href=\"https:\/\/www.m3globalresearch.com\/research\/?hh_id=54589&amp;utm_source=Blog%2FOncologyFocus&amp;utm_medium=NewOncologyTreatments-o-Link&amp;utm_campaign=Blog+New+oncology+treatments+23%09&amp;utm_id=54589&amp;utm_content=Link\">M3 Oncology Panel<\/a>. Get paid for participating via <a href=\"https:\/\/m3globalresearch.blog\/m3-wallet\/\" target=\"_blank\" rel=\"noopener\">M3 Wallet<\/a>.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-429b621 elementor-widget elementor-widget-text-editor\" data-id=\"429b621\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p>Find a list of available paid oncology studies on the \u201c<a href=\"https:\/\/m3globalresearch.blog\/available-medical-studies\/\" target=\"_blank\" rel=\"noopener\">Available Medical Studies<\/a>\u201d webpage or follow us on <a href=\"https:\/\/www.linkedin.com\/company\/10557915\" target=\"_blank\" rel=\"noopener\">LinkedIn<\/a> and <a href=\"https:\/\/twitter.com\/m3community\" target=\"_blank\" rel=\"noopener\">Twitter<\/a> for regular study updates.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-d367e99 elementor-widget elementor-widget-text-editor\" data-id=\"d367e99\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p>As a member, you can check out your `<a href=\"https:\/\/www.m3globalresearch.com\/research\/login\/?utm_source=Blog%2FOncologyFocusLogin&amp;utm_medium=NewOncologyTreatments-o-CTABox&amp;utm_campaign=Blog+New+oncology+treatments+23%09&amp;utm_id=54589&amp;utm_content=CTABox\" target=\"_blank\" rel=\"noopener\">Study Dashboard<\/a>\u00b4 to access the latest and best-paid studies that match your M3 profile. To avoid screening out and get more relevant study invitations that match your profession, specialty, and medical experience, read our <a href=\"https:\/\/m3globalresearch.blog\/2022\/07\/15\/screenout-paid-market-research\/\" target=\"_blank\" rel=\"noopener\">M3 Screener Guide<\/a>.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-100e325 elementor-widget elementor-widget-spacer\" data-id=\"100e325\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-99883b9 elementor-hidden-tablet elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"99883b9\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;_ha_eqh_enable&quot;:false}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-ca80a28\" data-id=\"ca80a28\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-fd99175 elementor-cta--layout-image-above elementor-hidden-desktop elementor-hidden-tablet elementor-cta--skin-classic elementor-animated-content elementor-bg-transform elementor-bg-transform-zoom-in elementor-widget elementor-widget-call-to-action\" data-id=\"fd99175\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"call-to-action.default\">\n\t\t\t\t\t\t\t<div class=\"elementor-cta\">\n\t\t\t\t\t<div class=\"elementor-cta__bg-wrapper\">\n\t\t\t\t<div class=\"elementor-cta__bg elementor-bg\" style=\"background-image: url(https:\/\/www.m3globalresearch.com\/blog\/wp-content\/uploads\/2023\/04\/new-oncology-treatments-1024x576.jpg);\" role=\"img\" aria-label=\"new oncology treatments\"><\/div>\n\t\t\t\t<div class=\"elementor-cta__bg-overlay\"><\/div>\n\t\t\t<\/div>\n\t\t\t\t\t\t\t<div class=\"elementor-cta__content\">\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\t\t\t\t\t<div class=\"elementor-cta__description elementor-cta__content-item elementor-content-item\">\n\t\t\t\t\t\tDid you find this article \"New Oncology Treatments 2023\"  interesting? We would like to invite you to participate in oncology surveys. Join today!\t\t\t\t\t<\/div>\n\t\t\t\t\n\t\t\t\t\t\t\t\t\t<div class=\"elementor-cta__button-wrapper elementor-cta__content-item elementor-content-item \">\n\t\t\t\t\t<a class=\"elementor-cta__button elementor-button elementor-size-\" href=\"https:\/\/www.m3globalresearch.com\/research\/?hh_id=54589&#038;utm_source=Blog%2FOncologyFocus&#038;utm_medium=NewOncologyTreatments-o-CTABox&#038;utm_campaign=Blog+New+oncology+treatments+23%09&#038;utm_id=54589&#038;utm_content=CTABox\">\n\t\t\t\t\t\tSign up\t\t\t\t\t<\/a>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-b11b91b elementor-cta--layout-image-left elementor-hidden-mobile elementor-cta--skin-classic elementor-animated-content elementor-bg-transform elementor-bg-transform-zoom-in elementor-widget elementor-widget-call-to-action\" data-id=\"b11b91b\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"call-to-action.default\">\n\t\t\t\t\t\t\t<div class=\"elementor-cta\">\n\t\t\t\t\t<div class=\"elementor-cta__bg-wrapper\">\n\t\t\t\t<div class=\"elementor-cta__bg elementor-bg\" style=\"background-image: url(https:\/\/www.m3globalresearch.com\/blog\/wp-content\/uploads\/2023\/04\/new-oncology-treatments-1024x576.jpg);\" role=\"img\" aria-label=\"new oncology treatments\"><\/div>\n\t\t\t\t<div class=\"elementor-cta__bg-overlay\"><\/div>\n\t\t\t<\/div>\n\t\t\t\t\t\t\t<div class=\"elementor-cta__content\">\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\t\t\t\t\t<div class=\"elementor-cta__description elementor-cta__content-item elementor-content-item\">\n\t\t\t\t\t\tDid you find this article \"New Oncology Treatments 2023\"  interesting? We would like to invite you to participate in oncology surveys. Join today!\t\t\t\t\t<\/div>\n\t\t\t\t\n\t\t\t\t\t\t\t\t\t<div class=\"elementor-cta__button-wrapper elementor-cta__content-item elementor-content-item \">\n\t\t\t\t\t<a class=\"elementor-cta__button elementor-button elementor-size-\" href=\"https:\/\/www.m3globalresearch.com\/research\/?hh_id=54589&#038;utm_source=Blog%2FOncologyFocus&#038;utm_medium=NewOncologyTreatments-o-CTABox&#038;utm_campaign=Blog+New+oncology+treatments+23%09&#038;utm_id=54589&#038;utm_content=CTABox\">\n\t\t\t\t\t\tSign up\t\t\t\t\t<\/a>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t<div class=\"elementor-element elementor-element-c8132d6 e-flex e-con-boxed e-con e-parent\" data-id=\"c8132d6\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;_ha_eqh_enable&quot;:false}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-c418a9d elementor-widget elementor-widget-spacer\" data-id=\"c418a9d\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-11fc4a4 elementor-widget elementor-widget-heading\" data-id=\"11fc4a4\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h3 class=\"elementor-heading-title elementor-size-default\">You Might Be Interested in:<\/h3>\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-f06113b e-flex e-con-boxed e-con e-parent\" data-id=\"f06113b\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;_ha_eqh_enable&quot;:false}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-9099cbb elementor-grid-1 elementor-grid-tablet-1 elementor-posts--thumbnail-left elementor-grid-mobile-1 elementor-widget elementor-widget-posts\" data-id=\"9099cbb\" data-element_type=\"widget\" data-e-type=\"widget\" data-settings=\"{&quot;classic_columns&quot;:&quot;1&quot;,&quot;classic_columns_tablet&quot;:&quot;1&quot;,&quot;classic_row_gap&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:50,&quot;sizes&quot;:[]},&quot;classic_columns_mobile&quot;:&quot;1&quot;,&quot;classic_row_gap_tablet&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;&quot;,&quot;sizes&quot;:[]},&quot;classic_row_gap_mobile&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:&quot;&quot;,&quot;sizes&quot;:[]}}\" data-widget_type=\"posts.classic\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-posts-container elementor-posts elementor-posts--skin-classic elementor-grid\" role=\"list\">\n\t\t\t\t<article class=\"elementor-post elementor-grid-item post-7061 post type-post status-publish format-standard has-post-thumbnail hentry category-monthly-pulse tag-assistenza-centrata-sul-paziente tag-atencion-centrada-en-el-paciente tag-avis-des-patients tag-blog-for-patients tag-blog-fur-patienten tag-blog-para-pacientes tag-blog-per-pazienti tag-blog-pour-les-patients tag-blog-til-patienter tag-blogg-for-pasienter tag-blogg-for-patienter tag-blogi-potilaille tag-communaute-de-patients tag-comunidad-de-pacientes tag-comunita-di-pazienti tag-data-beskyttelse tag-data-protection tag-datan-suojelu tag-dataskydd tag-datenschutz tag-dati-medici tag-datos-medicos-donnees-medicales tag-esperienza-dei-pazienti tag-etude-de-marche-pour-les-patients-ricerche-di-mercato-per-pazienti tag-experiencia-de-los-pacientes tag-facebook tag-facebook-preventive-health tag-forebyggande-halsa tag-forebyggende-helbred-ennaltaehkaiseva-terveys tag-forebyggende-helse tag-gesundheitstechnik tag-halsovard tag-halsovardsteknik tag-healthcare-innovations tag-healthcare-technology tag-healthy-tools tag-helseinnovasjoner tag-helseteknologi tag-herramienta-de-salud-preventiva tag-innovaciones-sanitarias tag-innovationen-im-gesundheitswesen tag-innovations-en-sante tag-innovazioni-sanitarie tag-investigacion-de-mercado-para-pacientes tag-lexperience-des-patients tag-laaketieteelliset-tiedot tag-markedsundersogelser-for-patienter tag-markedsundersokelser-for-pasienter tag-market-research-for-patients-marktforschung-fur-patienten tag-markkinatutkimus-potilaille tag-marknadsundersokningar-for-patienter tag-medical-data tag-medicinsk-information tag-medicinske-data tag-medisinsk tag-medizinische-daten tag-meinung-des-patienten tag-old-pulse tag-opinion-del-paciente tag-opinione-dei-pazienti tag-pasienter-mening tag-pasienter-patients-opinion tag-pasientfellesskap tag-pasientsentrert-omsorg tag-patient-centred-care tag-patientcentrerad-vard tag-patientcentreret-pleje tag-patientenerfahrung tag-patientengemeinschaft tag-patientenzentrierte-pflege tag-patienter-oplever tag-patienter-upplever tag-patienterna tag-patienters-mening tag-patientfaellesskab tag-patients-community tag-patients-experience tag-potilaiden-kokemus tag-potilaiden-mielipide tag-potilaskeskeinen-hoito tag-potilasyhteiso tag-preventive-health tag-proteccion-de-datos tag-protection-des-donnees tag-protezione-dati tag-red-social-reseau-social tag-salud-preventiva-sante-preventive tag-salute-preventiva tag-social-network tag-sociala-natverk tag-sociale-netvaerk tag-soins-centres-sur-le-patient tag-sosiaaliset-verkostot tag-sosiale-nettverk tag-soziales-netzwerk tag-sundhedsvaesensteknologi-terveydenhuollon-tekniikka tag-sundhedsydelser tag-tecnologia-sanitaria tag-tecnologia-sanitaria-la-technologie-des-soins-de-sante tag-terveydenhuollon-innovaatiot tag-vorbeugende-gesundheit\" role=\"listitem\">\n\t\t\t\t<a class=\"elementor-post__thumbnail__link\" href=\"https:\/\/www.m3globalresearch.com\/blog\/facebooks-preventative-health-tool-try\/\" tabindex=\"-1\" >\n\t\t\t<div class=\"elementor-post__thumbnail\"><img fetchpriority=\"high\" decoding=\"async\" width=\"2560\" height=\"1231\" src=\"https:\/\/www.m3globalresearch.com\/blog\/wp-content\/uploads\/2020\/02\/FBSURVEY-scaled.jpg\" class=\"attachment-full size-full wp-image-7063\" alt=\"Facebook\u2019s Preventive Health Tool\" srcset=\"https:\/\/www.m3globalresearch.com\/blog\/wp-content\/uploads\/2020\/02\/FBSURVEY-scaled.jpg 2560w, https:\/\/www.m3globalresearch.com\/blog\/wp-content\/uploads\/2020\/02\/FBSURVEY-300x144.jpg 300w, https:\/\/www.m3globalresearch.com\/blog\/wp-content\/uploads\/2020\/02\/FBSURVEY-1024x493.jpg 1024w, https:\/\/www.m3globalresearch.com\/blog\/wp-content\/uploads\/2020\/02\/FBSURVEY-768x369.jpg 768w, https:\/\/www.m3globalresearch.com\/blog\/wp-content\/uploads\/2020\/02\/FBSURVEY-1536x739.jpg 1536w, https:\/\/www.m3globalresearch.com\/blog\/wp-content\/uploads\/2020\/02\/FBSURVEY-2048x985.jpg 2048w\" sizes=\"(max-width: 2560px) 100vw, 2560px\" \/><\/div>\n\t\t<\/a>\n\t\t\t\t<div class=\"elementor-post__text\">\n\t\t\t\t<h3 class=\"elementor-post__title\">\n\t\t\t<a href=\"https:\/\/www.m3globalresearch.com\/blog\/facebooks-preventative-health-tool-try\/\" >\n\t\t\t\tFacebook\u2019s Preventive Health Tool &#8211; Would You Try It?\t\t\t<\/a>\n\t\t<\/h3>\n\t\t\t\t<div class=\"elementor-post__meta-data\">\n\t\t\t\t\t<span class=\"elementor-post-date\">\n\t\t\tFebruary 10, 2020\t\t<\/span>\n\t\t\t\t<span class=\"elementor-post-avatar\">\n\t\t\tNo Comments\t\t<\/span>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-post__excerpt\">\n\t\t\t<p>Facebook recently launched \u201cPreventive Health\u201d, a tool where users can share their health information with the social media service and receive reminders for key health check-ups, tests, and screenings. Facebook\u2019s reminders and the tool is<\/p>\n\t\t<\/div>\n\t\t\n\t\t<a class=\"elementor-post__read-more\" href=\"https:\/\/www.m3globalresearch.com\/blog\/facebooks-preventative-health-tool-try\/\" aria-label=\"Read more about Facebook\u2019s Preventive Health Tool &#8211; Would You Try It?\" tabindex=\"-1\" >\n\t\t\tRead More\t\t<\/a>\n\n\t\t\t\t<\/div>\n\t\t\t\t<\/article>\n\t\t\t\t<article class=\"elementor-post elementor-grid-item post-4516 post type-post status-publish format-standard has-post-thumbnail hentry category-patients-experience tag-acute-lymphocytic-leukaemia tag-adriamycin tag-all tag-arzt-vor-ort tag-arzte-netzwerk tag-arzteforum tag-basta-online-lakare tag-bedste-online-laege tag-behandlingsplan tag-behandlungsplan tag-benefits-for-cancer-patients tag-best-online-doctor tag-beste-online-lege tag-bester-online-arzt tag-betalade-undersokningar tag-betalte-undersogelser tag-betalte-undersokelser tag-bezahlte-umfragen tag-blod-cancer tag-blodkraeft tag-blodkreft tag-blog-about-healthcare tag-blog-for-doctors tag-blog-for-patients tag-blog-fur-arzte tag-blog-fur-patienten tag-blog-om-sundhedsydelser tag-blog-para-doctores tag-blog-para-pacientes tag-blog-per-medici tag-blog-per-pazienti tag-blog-pour-les-medecins tag-blog-pour-les-patients tag-blog-sobre-salud tag-blog-sullassistenza-sanitaria tag-blog-sur-les-soins-de-sante tag-blog-til-patienter tag-blog-uber-gesundheitswesen tag-blogg-for-lakare tag-blogg-for-leger tag-blogg-for-pasienter tag-blogg-for-patienter tag-blogg-om-helsevesen tag-blogga-om-sjukvard tag-blogi-laakareille tag-blogi-potilaille tag-blogi-terveydenhuollosta tag-blood-cancer tag-blood-cancer-awareness tag-blood-cancer-nhs tag-blood-cancer-treatment tag-blood-cancer-types tag-blutkrebs tag-bone-marrow tag-breast-cancer tag-cancer-de-sangre tag-cancer-family-support tag-cancer-help tag-cancer-support-groups tag-cancer-treatment tag-canceroperation tag-cancerpatient tag-cancro-al-sangue tag-chemioterapia tag-chemotherapie tag-chemotherapy tag-childhood-leukaemia tag-children tag-childrens-hospital-of-philadelphia tag-chimiotherapie tag-chirurgia-del-cancro tag-chirurgie-du-cancer tag-chop tag-cirugia-de-cancer tag-communaute-de-medecins tag-community-of-doctors tag-comunidad-de-doctores tag-comunita-di-medici tag-diet-for-cancer-patients tag-doctor-forum tag-doctor-site tag-doctors tag-doctors-network tag-doktorforum tag-encuestas-pagadas tag-end-of-life-cancer-symptoms tag-end-of-life-signs-in-cancer-patients tag-esperienza-dei-pazienti tag-etude-de-marche-de-la-sante tag-eukaemia-survivor tag-experiencia-de-los-pacientes tag-forum-de-docteur tag-forum-medico tag-full-blood-count-cancer tag-gemeinschaft-von-arzten tag-healthcare tag-healthcare-market-research tag-healthcare-professionals tag-healthcare-research tag-healthy tag-heredity tag-hoitosuunnitelma tag-hospital tag-investigacion-de-mercado-sanitario tag-joint-pain tag-kemoterapi tag-kemoterapia tag-kjemoterapi tag-kraeftkirurgi tag-kraeftpatienter tag-krebsoperation tag-krebspatient tag-kreftkirurgi tag-kreftpasient tag-lexperience-des-patients tag-laakareiden-verkosto tag-laakari-foorumi tag-laakarin-sivusto tag-laege-forum tag-laege-site tag-laeger-netvaerk tag-laegeres-samfund-laakareiden-yhteiso tag-lakarnatverk tag-lakarsamhalle tag-lakarsida tag-legeforum tag-leger-nettverk tag-legeside tag-leucemia tag-leucemie tag-leukaemi tag-leukaemia tag-leukamie tag-leukamie-uberlebender tag-leukemi tag-leukemia tag-leukemia-cancer tag-leukemia-selviytyja tag-low-platelets-cancer tag-m3 tag-m3-blog tag-m3-global-research tag-m3-panel tag-m3globalresearch tag-maksetut-tutkimukset tag-malato-di-cancro tag-markedsundersogelse-inden-for-sundhedsydelser tag-markedsundersokelser-innen-helsevesenet tag-market-research tag-marknadsundersokningar-inom-sjukvarden tag-marktforschung-im-gesundheitswesen tag-medical-data tag-medical-treatment tag-meilleur-docteur-en-ligne tag-mejor-doctor-en-linea tag-methotrexate tag-miglior-medico-online tag-multiple-myeloma tag-myeloma tag-myeloma-cancer tag-myeloma-prognosis tag-oral-chemotherapy tag-oral-prednisone tag-overlevande-av-leukemi tag-overlevende-af-leukaemi tag-overlevende-av-leukemi tag-paciente-con-cancer tag-paid-surveys tag-paras-online-laakari tag-pasienter-opplever tag-patient-atteint-de-cancer tag-patientenerfahrung tag-patienter-oplever tag-patienter-upplever tag-patients tag-patients-experience tag-pennsylvania tag-philadelphia tag-piano-di-trattamento tag-plan-de-traitement tag-plan-de-tratamiento tag-potilaiden-kokemus tag-psa-check tag-psa-levels tag-quimioterapia tag-raised-psa-levels tag-red-de-medicos tag-reseau-de-medecins tag-rete-di-medici tag-ricerche-di-mercato-nel-settore-sanitario tag-septic-arthritis tag-site-du-medecin tag-sitio-del-doctor tag-sito-medico tag-sobreviviente-de-leucemia tag-sondages-remuneres-sondaggi-retribuiti tag-sopravvissuto-alla-leucemia tag-spinal-taps tag-survivant-de-leucemie tag-swelling tag-syopaleikkaus tag-syopapotilas tag-syringes tag-terveydenhuollon-markkinatutkimus tag-therapist tag-treatment tag-treatment-plan tag-united-states tag-verisyopa tag-vincristine\" role=\"listitem\">\n\t\t\t\t<a class=\"elementor-post__thumbnail__link\" href=\"https:\/\/www.m3globalresearch.com\/blog\/meet-nicole\/\" tabindex=\"-1\" >\n\t\t\t<div class=\"elementor-post__thumbnail\"><img decoding=\"async\" width=\"2560\" height=\"1015\" src=\"https:\/\/www.m3globalresearch.com\/blog\/wp-content\/uploads\/2019\/09\/meetnicole_Cropped-scaled.jpg\" class=\"attachment-full size-full wp-image-7046\" alt=\"\" srcset=\"https:\/\/www.m3globalresearch.com\/blog\/wp-content\/uploads\/2019\/09\/meetnicole_Cropped-scaled.jpg 2560w, https:\/\/www.m3globalresearch.com\/blog\/wp-content\/uploads\/2019\/09\/meetnicole_Cropped-300x119.jpg 300w, https:\/\/www.m3globalresearch.com\/blog\/wp-content\/uploads\/2019\/09\/meetnicole_Cropped-1024x406.jpg 1024w, https:\/\/www.m3globalresearch.com\/blog\/wp-content\/uploads\/2019\/09\/meetnicole_Cropped-768x305.jpg 768w, https:\/\/www.m3globalresearch.com\/blog\/wp-content\/uploads\/2019\/09\/meetnicole_Cropped-1536x609.jpg 1536w, https:\/\/www.m3globalresearch.com\/blog\/wp-content\/uploads\/2019\/09\/meetnicole_Cropped-2048x812.jpg 2048w\" sizes=\"(max-width: 2560px) 100vw, 2560px\" \/><\/div>\n\t\t<\/a>\n\t\t\t\t<div class=\"elementor-post__text\">\n\t\t\t\t<h3 class=\"elementor-post__title\">\n\t\t\t<a href=\"https:\/\/www.m3globalresearch.com\/blog\/meet-nicole\/\" >\n\t\t\t\tMeet Nicole&#8230;\t\t\t<\/a>\n\t\t<\/h3>\n\t\t\t\t<div class=\"elementor-post__meta-data\">\n\t\t\t\t\t<span class=\"elementor-post-date\">\n\t\t\tSeptember 27, 2019\t\t<\/span>\n\t\t\t\t<span class=\"elementor-post-avatar\">\n\t\t\t2 Comments\t\t<\/span>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-post__excerpt\">\n\t\t\t<p>Nicole is a 37-year-old leukaemia survivor who lives outside of Philadelphia, Pennsylvania, in the United States. She was diagnosed just after turning eight-years-old when she was in third grade. Nicole was diagnosed just a\u00ad after<\/p>\n\t\t<\/div>\n\t\t\n\t\t<a class=\"elementor-post__read-more\" href=\"https:\/\/www.m3globalresearch.com\/blog\/meet-nicole\/\" aria-label=\"Read more about Meet Nicole&#8230;\" tabindex=\"-1\" >\n\t\t\tRead More\t\t<\/a>\n\n\t\t\t\t<\/div>\n\t\t\t\t<\/article>\n\t\t\t\t<\/div>\n\t\t\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-ff640e6 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"ff640e6\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;_ha_eqh_enable&quot;:false}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-33 elementor-top-column elementor-element elementor-element-c3d1062\" data-id=\"c3d1062\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-3ef88f8 elementor-widget elementor-widget-spacer\" data-id=\"3ef88f8\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t<div class=\"elementor-column elementor-col-33 elementor-top-column elementor-element elementor-element-cd74626\" data-id=\"cd74626\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-c18d446 elementor-widget elementor-widget-spacer\" data-id=\"c18d446\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-f0689ff elementor-align-center elementor-mobile-align-center elementor-widget elementor-widget-button\" data-id=\"f0689ff\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"button.default\">\n\t\t\t\t\t\t\t\t\t\t<a class=\"elementor-button elementor-button-link elementor-size-sm elementor-animation-grow\" href=\"https:\/\/m3globalresearch.blog\/\">\n\t\t\t\t\t\t<span class=\"elementor-button-content-wrapper\">\n\t\t\t\t\t\t\t\t\t<span class=\"elementor-button-text\">M3 Blog Index<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t<div class=\"elementor-column elementor-col-33 elementor-top-column elementor-element elementor-element-fba9ab9\" data-id=\"fba9ab9\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-a95a3f4 elementor-widget elementor-widget-spacer\" data-id=\"a95a3f4\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false,"gt_translate_keys":[{"key":"rendered","format":"html"}]},"excerpt":{"rendered":"<p>Between January 2020 and March 2023, over 170 new oncology treatments were approved by the FDA. New approvals for the first quarter of 2023 include treatments for non-small cell lung cancer (NSCLC), breast cancer, prostate cancer, and leukaemia.<\/p>\n","protected":false,"gt_translate_keys":[{"key":"rendered","format":"html"}]},"author":1,"featured_media":144985,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_eb_attr":"","_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[8200,8134,8201],"tags":[6043,354,2875,7773,1872],"class_list":["post-144947","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-healthcare","category-oncology-focus","category-physician-hub","tag-cancer-treatments","tag-healthcare-market-research","tag-oncology","tag-ph","tag-physician-opinion"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.6 (Yoast SEO v27.7) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>New Oncology Treatments 2023<\/title>\n<meta name=\"description\" content=\"New oncology treatments for non-small cell lung cancer (NSCLC), breast cancer, prostate cancer, and leukaemia have been approved by FDA...\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.m3globalresearch.com\/blog\/new-oncology-treatments-2023-nsclc-breast-cancer-prostate-cancer-and-leukaemia\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"New Oncology Treatments 2023\" \/>\n<meta property=\"og:description\" content=\"New oncology treatments for non-small cell lung cancer (NSCLC), breast cancer, prostate cancer, and leukaemia have been approved by FDA...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.m3globalresearch.com\/blog\/new-oncology-treatments-2023-nsclc-breast-cancer-prostate-cancer-and-leukaemia\/\" \/>\n<meta property=\"og:site_name\" content=\"M3 Global Research\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/en-gb.facebook.com\/M3GlobalResearch\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-12T09:18:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.m3globalresearch.com\/blog\/wp-content\/uploads\/2023\/04\/new-oncology-treatments-1024x576.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"576\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"m3gr-blog-admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@M3GR_Community\" \/>\n<meta name=\"twitter:site\" content=\"@M3GR_Community\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"m3gr-blog-admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"7 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/new-oncology-treatments-2023-nsclc-breast-cancer-prostate-cancer-and-leukaemia\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/new-oncology-treatments-2023-nsclc-breast-cancer-prostate-cancer-and-leukaemia\\\/\"},\"author\":{\"name\":\"m3gr-blog-admin\",\"@id\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/#\\\/schema\\\/person\\\/11bace963d7a45380011c4911a822a6c\"},\"headline\":\"New Oncology Treatments 2023\",\"datePublished\":\"2023-04-12T09:18:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/new-oncology-treatments-2023-nsclc-breast-cancer-prostate-cancer-and-leukaemia\\\/\"},\"wordCount\":1208,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/new-oncology-treatments-2023-nsclc-breast-cancer-prostate-cancer-and-leukaemia\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/new-oncology-treatments-scaled.jpg\",\"keywords\":[\"cancer treatments\",\"healthcare market research\",\"oncology\",\"PH\",\"physician opinion\"],\"articleSection\":[\"Healthcare\",\"Oncology Focus\",\"Physician Hub\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/new-oncology-treatments-2023-nsclc-breast-cancer-prostate-cancer-and-leukaemia\\\/#respond\"]}]},{\"@type\":[\"WebPage\",\"MedicalWebPage\"],\"@id\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/new-oncology-treatments-2023-nsclc-breast-cancer-prostate-cancer-and-leukaemia\\\/\",\"url\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/new-oncology-treatments-2023-nsclc-breast-cancer-prostate-cancer-and-leukaemia\\\/\",\"name\":\"New Oncology Treatments 2023\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/new-oncology-treatments-2023-nsclc-breast-cancer-prostate-cancer-and-leukaemia\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/new-oncology-treatments-2023-nsclc-breast-cancer-prostate-cancer-and-leukaemia\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/new-oncology-treatments-scaled.jpg\",\"datePublished\":\"2023-04-12T09:18:03+00:00\",\"description\":\"New oncology treatments for non-small cell lung cancer (NSCLC), breast cancer, prostate cancer, and leukaemia have been approved by FDA...\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/new-oncology-treatments-2023-nsclc-breast-cancer-prostate-cancer-and-leukaemia\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/new-oncology-treatments-2023-nsclc-breast-cancer-prostate-cancer-and-leukaemia\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/new-oncology-treatments-2023-nsclc-breast-cancer-prostate-cancer-and-leukaemia\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/new-oncology-treatments-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/new-oncology-treatments-scaled.jpg\",\"width\":3840,\"height\":2160,\"caption\":\"new oncology treatments\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/new-oncology-treatments-2023-nsclc-breast-cancer-prostate-cancer-and-leukaemia\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"paid medical surveys for physicians\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/#website\",\"url\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/\",\"name\":\"M3 Global Research\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/#organization\",\"name\":\"M3 Global Research\",\"url\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":null,\"contentUrl\":null,\"width\":null,\"height\":null,\"caption\":\"M3 Global Research\"},\"image\":{\"@id\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/en-gb.facebook.com\\\/M3GlobalResearch\\\/\",\"https:\\\/\\\/x.com\\\/M3GR_Community\",\"https:\\\/\\\/www.instagram.com\\\/m3globalresearch\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/10557915\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/#\\\/schema\\\/person\\\/11bace963d7a45380011c4911a822a6c\",\"name\":\"m3gr-blog-admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/fb0c444d9d8b383c405133f87af6215220f0327b7f797aec37db4ab6b6b18364?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/fb0c444d9d8b383c405133f87af6215220f0327b7f797aec37db4ab6b6b18364?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/fb0c444d9d8b383c405133f87af6215220f0327b7f797aec37db4ab6b6b18364?s=96&d=mm&r=g\",\"caption\":\"m3gr-blog-admin\"},\"sameAs\":[\"https:\\\/\\\/blog.m3globalresearch.com\"],\"url\":\"https:\\\/\\\/www.m3globalresearch.com\\\/blog\\\/author\\\/m3gr-blog-admin\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"New Oncology Treatments 2023","description":"New oncology treatments for non-small cell lung cancer (NSCLC), breast cancer, prostate cancer, and leukaemia have been approved by FDA...","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.m3globalresearch.com\/blog\/new-oncology-treatments-2023-nsclc-breast-cancer-prostate-cancer-and-leukaemia\/","og_locale":"en_US","og_type":"article","og_title":"New Oncology Treatments 2023","og_description":"New oncology treatments for non-small cell lung cancer (NSCLC), breast cancer, prostate cancer, and leukaemia have been approved by FDA...","og_url":"https:\/\/www.m3globalresearch.com\/blog\/new-oncology-treatments-2023-nsclc-breast-cancer-prostate-cancer-and-leukaemia\/","og_site_name":"M3 Global Research","article_publisher":"https:\/\/en-gb.facebook.com\/M3GlobalResearch\/","article_published_time":"2023-04-12T09:18:03+00:00","og_image":[{"width":1024,"height":576,"url":"https:\/\/www.m3globalresearch.com\/blog\/wp-content\/uploads\/2023\/04\/new-oncology-treatments-1024x576.jpg","type":"image\/jpeg"}],"author":"m3gr-blog-admin","twitter_card":"summary_large_image","twitter_creator":"@M3GR_Community","twitter_site":"@M3GR_Community","twitter_misc":{"Written by":"m3gr-blog-admin","Est. reading time":"7 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.m3globalresearch.com\/blog\/new-oncology-treatments-2023-nsclc-breast-cancer-prostate-cancer-and-leukaemia\/#article","isPartOf":{"@id":"https:\/\/www.m3globalresearch.com\/blog\/new-oncology-treatments-2023-nsclc-breast-cancer-prostate-cancer-and-leukaemia\/"},"author":{"name":"m3gr-blog-admin","@id":"https:\/\/www.m3globalresearch.com\/blog\/#\/schema\/person\/11bace963d7a45380011c4911a822a6c"},"headline":"New Oncology Treatments 2023","datePublished":"2023-04-12T09:18:03+00:00","mainEntityOfPage":{"@id":"https:\/\/www.m3globalresearch.com\/blog\/new-oncology-treatments-2023-nsclc-breast-cancer-prostate-cancer-and-leukaemia\/"},"wordCount":1208,"commentCount":0,"publisher":{"@id":"https:\/\/www.m3globalresearch.com\/blog\/#organization"},"image":{"@id":"https:\/\/www.m3globalresearch.com\/blog\/new-oncology-treatments-2023-nsclc-breast-cancer-prostate-cancer-and-leukaemia\/#primaryimage"},"thumbnailUrl":"https:\/\/www.m3globalresearch.com\/blog\/wp-content\/uploads\/2023\/04\/new-oncology-treatments-scaled.jpg","keywords":["cancer treatments","healthcare market research","oncology","PH","physician opinion"],"articleSection":["Healthcare","Oncology Focus","Physician Hub"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.m3globalresearch.com\/blog\/new-oncology-treatments-2023-nsclc-breast-cancer-prostate-cancer-and-leukaemia\/#respond"]}]},{"@type":["WebPage","MedicalWebPage"],"@id":"https:\/\/www.m3globalresearch.com\/blog\/new-oncology-treatments-2023-nsclc-breast-cancer-prostate-cancer-and-leukaemia\/","url":"https:\/\/www.m3globalresearch.com\/blog\/new-oncology-treatments-2023-nsclc-breast-cancer-prostate-cancer-and-leukaemia\/","name":"New Oncology Treatments 2023","isPartOf":{"@id":"https:\/\/www.m3globalresearch.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.m3globalresearch.com\/blog\/new-oncology-treatments-2023-nsclc-breast-cancer-prostate-cancer-and-leukaemia\/#primaryimage"},"image":{"@id":"https:\/\/www.m3globalresearch.com\/blog\/new-oncology-treatments-2023-nsclc-breast-cancer-prostate-cancer-and-leukaemia\/#primaryimage"},"thumbnailUrl":"https:\/\/www.m3globalresearch.com\/blog\/wp-content\/uploads\/2023\/04\/new-oncology-treatments-scaled.jpg","datePublished":"2023-04-12T09:18:03+00:00","description":"New oncology treatments for non-small cell lung cancer (NSCLC), breast cancer, prostate cancer, and leukaemia have been approved by FDA...","breadcrumb":{"@id":"https:\/\/www.m3globalresearch.com\/blog\/new-oncology-treatments-2023-nsclc-breast-cancer-prostate-cancer-and-leukaemia\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.m3globalresearch.com\/blog\/new-oncology-treatments-2023-nsclc-breast-cancer-prostate-cancer-and-leukaemia\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.m3globalresearch.com\/blog\/new-oncology-treatments-2023-nsclc-breast-cancer-prostate-cancer-and-leukaemia\/#primaryimage","url":"https:\/\/www.m3globalresearch.com\/blog\/wp-content\/uploads\/2023\/04\/new-oncology-treatments-scaled.jpg","contentUrl":"https:\/\/www.m3globalresearch.com\/blog\/wp-content\/uploads\/2023\/04\/new-oncology-treatments-scaled.jpg","width":3840,"height":2160,"caption":"new oncology treatments"},{"@type":"BreadcrumbList","@id":"https:\/\/www.m3globalresearch.com\/blog\/new-oncology-treatments-2023-nsclc-breast-cancer-prostate-cancer-and-leukaemia\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.m3globalresearch.com\/blog\/"},{"@type":"ListItem","position":2,"name":"paid medical surveys for physicians"}]},{"@type":"WebSite","@id":"https:\/\/www.m3globalresearch.com\/blog\/#website","url":"https:\/\/www.m3globalresearch.com\/blog\/","name":"M3 Global Research","description":"","publisher":{"@id":"https:\/\/www.m3globalresearch.com\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.m3globalresearch.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.m3globalresearch.com\/blog\/#organization","name":"M3 Global Research","url":"https:\/\/www.m3globalresearch.com\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.m3globalresearch.com\/blog\/#\/schema\/logo\/image\/","url":null,"contentUrl":null,"width":null,"height":null,"caption":"M3 Global Research"},"image":{"@id":"https:\/\/www.m3globalresearch.com\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/en-gb.facebook.com\/M3GlobalResearch\/","https:\/\/x.com\/M3GR_Community","https:\/\/www.instagram.com\/m3globalresearch","https:\/\/www.linkedin.com\/company\/10557915"]},{"@type":"Person","@id":"https:\/\/www.m3globalresearch.com\/blog\/#\/schema\/person\/11bace963d7a45380011c4911a822a6c","name":"m3gr-blog-admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/fb0c444d9d8b383c405133f87af6215220f0327b7f797aec37db4ab6b6b18364?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/fb0c444d9d8b383c405133f87af6215220f0327b7f797aec37db4ab6b6b18364?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/fb0c444d9d8b383c405133f87af6215220f0327b7f797aec37db4ab6b6b18364?s=96&d=mm&r=g","caption":"m3gr-blog-admin"},"sameAs":["https:\/\/blog.m3globalresearch.com"],"url":"https:\/\/www.m3globalresearch.com\/blog\/author\/m3gr-blog-admin\/"}]}},"jetpack_featured_media_url":"https:\/\/www.m3globalresearch.com\/blog\/wp-content\/uploads\/2023\/04\/new-oncology-treatments-scaled.jpg","jetpack_sharing_enabled":true,"gt_translate_keys":[{"key":"link","format":"url"}],"_links":{"self":[{"href":"https:\/\/www.m3globalresearch.com\/blog\/wp-json\/wp\/v2\/posts\/144947","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.m3globalresearch.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.m3globalresearch.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.m3globalresearch.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.m3globalresearch.com\/blog\/wp-json\/wp\/v2\/comments?post=144947"}],"version-history":[{"count":0,"href":"https:\/\/www.m3globalresearch.com\/blog\/wp-json\/wp\/v2\/posts\/144947\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.m3globalresearch.com\/blog\/wp-json\/wp\/v2\/media\/144985"}],"wp:attachment":[{"href":"https:\/\/www.m3globalresearch.com\/blog\/wp-json\/wp\/v2\/media?parent=144947"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.m3globalresearch.com\/blog\/wp-json\/wp\/v2\/categories?post=144947"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.m3globalresearch.com\/blog\/wp-json\/wp\/v2\/tags?post=144947"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}